Old Web
English
Sign In
Acemap
>
authorDetail
>
Angélique Deleersnijder
Angélique Deleersnijder
European Organisation for Research and Treatment of Cancer
Medicine
Breast cancer
Capecitabine
Ovarian cancer
Gemcitabine
2
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Will molecular target agents enable the multidisciplinary treatment in stage IV gastric cancer
2017
Ejso
Kozo Kataoka
Angélique Deleersnijder
Florian Lordick
Show All
Source
Cite
Save
Citations (3)
A phase III randomized trial of niraparib versus physician’s choice in previously treated, HER2-negative, germline-BRCA mutated breast cancer patients: Intergroup study EORTC-1307-BCG and BIG5-13.
2014
Journal of Clinical Oncology
Konstantinos Tryfonidis
Jan Bogaerts
Robert E. Martell
George W. Sledge
Judith Balmaña
M. William Audeh
Angélique Deleersnijder
Felicia Favorito
Shefali Agarwal
Giovanna Rizzetto
Carlo G. M. Messina
Leen Slaets
Theodora Goulioti
Andrew Tutt
David Cameron
Nicholas C. Turner
Show All
Source
Cite
Save
Citations (9)
1